"10.1371_journal.pone.0107200","plos one","2014-09-23T00:00:00Z","Esther Conde; Ana Suárez-Gauthier; Amparo Benito; Pilar Garrido; Rosario García-Campelo; Michele Biscuola; Luis Paz-Ares; David Hardisson; Javier de Castro; M Carmen Camacho; Delvys Rodriguez-Abreu; Ihab Abdulkader; Josep Ramirez; Noemí Reguart; Marta Salido; Lara Pijuán; Edurne Arriola; Julián Sanz; Victoria Folgueras; Noemí Villanueva; Javier Gómez-Román; Manuel Hidalgo; Fernando López-Ríos","Laboratorio de Dianas Terapéuticas, Centro Integral Oncológico “Clara Campal”, Hospital Universitario Madrid Sanchinarro, Universidad San Pablo-CEU, Madrid, Spain; Hospital Ramón y Cajal, Madrid, Spain; C.H.U. A Coruña, La Coruña, Spain; Hospital Virgen del Rocío, Sevilla, Spain; IdiPAZ (Hospital La Paz Institute for Health Research), University Hospital La Paz, Faculty of Medicine, Autonomous University of Madrid, Madrid, Spain; Hospital Insular de Gran Canaria, Las Palmas de Gran Canaria, Spain; C.H.U. Santiago de Compostela, Santiago de Compostela, Spain; Hospital Clinic, Barcelona, Spain; Hospital del Mar-Parc de Salut Mar, Barcelona, Spain; Hospital Clínico San Carlos, Madrid, Spain; Hospital Central de Asturias, Oviedo, Spain; Hospital Marqués de Valdecilla, Santander, Spain; Oncology Department, Centro Integral Oncológico “Clara Campal”, Hospital Universitario Madrid Sanchinarro, Universidad San Pablo-CEU, Madrid, Spain","Conceived and designed the experiments: EC FL-R. Performed the experiments: EC FL-R AS-G. Analyzed the data: EC AS-G AB PG RG-C MB LP-A DH JC MCC DR-A IA JR NR MS LP EA JS VF NV JG-R MH FL-R. Contributed reagents/materials/analysis tools: EC AS-G AB PG RG-C MB LP-A DH JC MCC DR-A IA JR NR MS LP EA JS VF NV JG-R MH FL-R. Wrote the paper: EC AS-G AB PG RG-C MB LP-A DH JC MCC DR-A IA JR NR MS LP EA JS VF NV JG-R MH FL-R.","E. Conde and J. Gómez-Román: honoraria, Pfizer. M. Salido: Advisory Board, Pfizer. E. Arriola: Advisory Board and Research Funding, Pfizer. F. López-Ríos: Advisory Board and Research Funding, Pfizer. Research funding: Abbott and Ventana Medical Systems. Ventana Medical Systems provided reagents free of charge. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.","2014","09","Esther Conde","EC",23,TRUE,2,3,23,23,TRUE,TRUE,FALSE,0,NA,FALSE
